Skip to main content

Peters William J's Form 4 filing

Amphastar Pharmaceuticals, Inc. (AMPH) · filed Mar 6, 2025

Accession no.
0001415889-25-007241
Filed
Mar 6, 2025
Trade date
Mar 4, 2025
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $116.5K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Peters William JCIK 0001263136Director, Officer (CFO, EVP & TREASURER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 4, 2025Common StockMOption exerciseAcquired+7,490$13.35+$99,991.5101,594Direct
Mar 4, 2025Common StockSSaleDisposed−4,231$27.54−$116,521.7497,363Direct
Mar 4, 2025Common StockFTax withholdingDisposed−1,739$27.62−$48,031.1895,624Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 4, 2025Common StockMOption exerciseDisposed−7,490$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)